$ARWR ARROWHEAD PHARMACEUTICALS, INC. Insider Trading Week 21/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. in week 21/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2019 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 24.88 | 30,000 | 746,400 | 203,000 | 233 K to 203 K (-12.88 %) |
May 29 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 2.62 | 9,376 | 24,565 | 1,133,418 | |
May 29 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 2.01 | 40,072 | 80,545 | 1,142,794 | |
May 29 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 2.62 | 9,376 | 24,565 | 2,141,903 | 2.1 M to 2.1 M (+0.44 %) |
May 29 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 2.01 | 40,072 | 80,545 | 2,132,527 | 2.1 M to 2.1 M (+1.92 %) |